<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" 
        xmlns:image="http://www.google.com/schemas/sitemap-image/1.1">
  <url>
    <loc>https://openbell.ai/</loc>
    <lastmod>2026-10-19T13:30:00.913Z</lastmod>
    <changefreq>hourly</changefreq>
    <priority>1.0</priority>
  </url>
  <url>
    <loc>https://openbell.ai/support</loc>
    <lastmod>2026-10-19T13:30:00.913Z</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.7</priority>
  </url>
  <url>
    <loc>https://openbell.ai/privacy</loc>
    <lastmod>2026-10-19T13:30:00.913Z</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://openbell.ai/terms</loc>
    <lastmod>2026-10-19T13:30:00.913Z</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://openbell.ai/feed.json</loc>
    <lastmod>2026-10-19T13:30:00.913Z</lastmod>
    <changefreq>hourly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://openbell.ai/news/OXY:1792416595906</loc>
    <lastmod>2026-10-19T13:29:55.906Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/OXY/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Stephens &amp;amp; Co. Maintains Overweight on Occidental Petroleum, Raises Price Target to $80</image:title>
      <image:caption>Stephens &amp; Co. analyst Mike Scialla has maintained an Overweight rating on Occidental Petroleum (NYSE: OXY) and increased the price target from $78 to $80.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/QNT:1792416527874</loc>
    <lastmod>2026-10-19T13:28:47.874Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/QNT/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Quantinuum Stock Climbs as Helios Hits 99.9995% Logical Fidelity, Nearing 2029 Target</image:title>
      <image:caption>Quantinuum Inc. (NASDAQ: QNT) shares rose 5.34% to $38.49 following the announcement of a world-record quantum error-correction result from its Helios computer, achieving a logical fidelity of 99.9995%, which translates to five errors per million operations. This performance is ten times better than its previous record and significantly surpasses the best results from other hardware types. The company believes this advancement positions it closer to its goal of developing a fault-tolerant quantum computer by 2029, potentially requiring fewer qubits than competitors.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/TRV:1792416514888</loc>
    <lastmod>2026-10-19T13:28:34.888Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/TRV/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Truist Securities Maintains Buy on Travelers Companies, Raises Price Target to $435</image:title>
      <image:caption>Truist Securities analyst Mark Hughes has maintained a Buy rating on Travelers Companies (NYSE: TRV) and increased the price target from $425 to $435. This adjustment reflects a positive outlook for the company in the market.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/CVE:1792416424664</loc>
    <lastmod>2026-10-19T13:27:04.664Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/CVE/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Jefferies Maintains Buy on Cenovus Energy, Raises Price Target to C$54</image:title>
      <image:caption>Jefferies has reiterated a Buy rating on Cenovus Energy (TSX: CVE) and increased its price target from C$51 to C$54. This adjustment reflects a positive outlook for the company&#39;s stock performance.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/RVMD:1792416404170</loc>
    <lastmod>2026-10-19T13:26:44.170Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/RVMD/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Truist Securities Maintains Buy on Revolution Medicines, Raises Price Target to $241</image:title>
      <image:caption>Truist Securities analyst Gregory Renza has maintained a &#39;Buy&#39; rating on Revolution Medicines (NASDAQ: RVMD) and raised the price target from $240 to $241. This adjustment reflects a positive outlook for the company in the market.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/VRSN:1792416320728</loc>
    <lastmod>2026-10-19T13:25:20.728Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/VRSN/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Wedbush Maintains Outperform on VeriSign, Raises Price Target to $351</image:title>
      <image:caption>Wedbush analyst Ygal Arounian has maintained an &#39;Outperform&#39; rating on VeriSign (NASDAQ: VRSN) and raised the price target from $341 to $351. This adjustment reflects a positive outlook for the company&#39;s performance in the market.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/MSFT:1792416303480</loc>
    <lastmod>2026-10-19T13:25:03.480Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/MSFT/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Microsoft Expands Project Perception, CEO Satya Nadella Announces</image:title>
      <image:caption>Microsoft is expanding its Project Perception initiative, as announced by CEO Satya Nadella. The expansion aims to enhance the company&#39;s capabilities in artificial intelligence and machine learning. Specific financial figures or strategic details regarding the expansion were not disclosed in the announcement.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/CLF:1792416190671</loc>
    <lastmod>2026-10-19T13:23:10.671Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.benzinga.com/files/images/story/2026/10/19/Konskie--Poland---March-06--2025-Clevela.jpg?width=250&amp;height=187</image:loc>
      <image:title>Steelmaker Cleveland-Cliffs Delivers Strongest Quarter in Three Years</image:title>
      <image:caption>Cleveland-Cliffs Inc. reported adjusted earnings of 28 cents per share for the third quarter, surpassing analysts&#39; expectations of 19 cents, while revenue of $5.612 billion fell short of the $5.724 billion consensus. The company anticipates fourth-quarter adjusted EBITDA to rise to approximately $715 million and aims to significantly reduce debt through stronger free cash flow. Additionally, Cleveland-Cliffs&#39; stock rose by 15.68% to $14.02 in premarket trading following the announcement.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/GPRO:1792416150419</loc>
    <lastmod>2026-10-19T13:22:30.419Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/GPRO/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>GoPro Files Preliminary Proxy Statement; Proposed Merger With Starman Optical On Track; Companies Reaffirm Commitment To Completing Proposed Merger On Previously Announced Terms</image:title>
      <image:caption>GoPro, Inc. has filed a preliminary proxy statement with the SEC regarding its proposed merger with Starman Optical, Inc., reaffirming its commitment to complete the merger on previously announced terms. The company also noted that a financial restatement reflects non-cash accounting adjustments. This merger is part of GoPro&#39;s strategic plans as it continues to navigate its financial landscape.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/MVIS:1792416108967</loc>
    <lastmod>2026-10-19T13:21:48.967Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/MVIS/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>MicroVision Forms Alliance With Blue-Band To Provide Lidar-Powered Smart Infrastructure Services To Intelligence Transport System Market</image:title>
      <image:caption>MicroVision, Inc. (NASDAQ: MVIS) has formed an exclusive strategic alliance with Blue-Band LLC to provide lidar-powered smart infrastructure solutions for the intelligent transportation system market. This partnership aims to enhance MicroVision&#39;s capabilities in the ITS sector and accelerate revenue generation by offering scalable and cost-effective solutions for transportation agencies and infrastructure operators.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/CRWV:1792416092292</loc>
    <lastmod>2026-10-19T13:21:32.292Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.benzinga.com/files/images/story/2026/10/19/Coreweave.jpg?width=250&amp;height=187</image:loc>
      <image:title>Goldman Sachs Upgrades CoreWeave Despite 15% Bond Yields as Stock Jumps 6%</image:title>
      <image:caption>CoreWeave Inc. (NASDAQ: CRWV) shares rose 6% in premarket trading following an upgrade from Goldman Sachs, which moved the stock rating from Neutral to Buy. This upgrade comes despite a challenging bond market where yields on CoreWeave&#39;s debt have surged to nearly 15%. Analysts believe the company will manage its future expansion financing at reasonable costs, although concerns remain about its substantial borrowing needs, estimated at $35 billion, to support existing customer commitments.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/IMPP:1792416091420</loc>
    <lastmod>2026-10-19T13:21:31.420Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/IMPP/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Imperial Petroleum Estimates $691.1M NAV As Fleet Expands To 24 Vessels</image:title>
      <image:caption>Imperial Petroleum Inc. (NASDAQ: IMPP) estimates its Net Asset Value (NAV) at $691.1 million, equating to $14.93 per common share outstanding and $11.72 per fully diluted share. The company has expanded its fleet to 24 vessels following the recent delivery of three additional vessels: the drybulk carrier Eco Cathar and product tanker Clean Raider in late September 2026, and the drybulk carrier Eco Nemesis in early October 2026.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/GSAT:1792416053036</loc>
    <lastmod>2026-10-19T13:20:53.036Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/GSAT/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Globalstar Receives US FCC Issues Order Approval For Nationwide Authority To Operate Third-Generation C-3 MSS System</image:title>
      <image:caption>Globalstar, Inc. (NASDAQ: GSAT) has received approval from the U.S. Federal Communications Commission (FCC) to operate its third-generation C-3 MSS System nationwide. This authorization allows Globalstar&#39;s C-3 satellites to communicate with millions of mobile earth terminals in the U.S., including direct-to-device connectivity for smartphones. The approval marks a significant milestone in the long-standing collaboration between Globalstar and the FCC.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/XGN:1792415857152</loc>
    <lastmod>2026-10-19T13:17:37.152Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/XGN/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Canaccord Genuity Maintains Buy on Exagen, Raises Price Target to $11</image:title>
      <image:caption>Canaccord Genuity analyst Kyle Mikson has maintained a &#39;Buy&#39; rating on Exagen (NASDAQ: XGN) and raised the price target from $9 to $11. This adjustment reflects a positive outlook for the company in the market.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/YHC:1792415852077</loc>
    <lastmod>2026-10-19T13:17:32.077Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/YHC/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>LQR House&amp;#39;s YHC AI Enters Into A 1-Year Agreement To Procure Up To $3M In OpenAI-Powered Computing Resources To Advance AI-Driven Financial Research And Portfolio Optimization</image:title>
      <image:caption>LQR House Inc. (NASDAQ: YHC) announced that its subsidiary YHC AI Limited has signed a one-year agreement to procure up to $3 million in OpenAI-powered computing resources. This initiative aims to enhance AI-driven financial research and portfolio optimization at Fusion Five Continents Securities Limited, another subsidiary of LQR House. The agreement is part of the company&#39;s strategy to develop a flexible AI infrastructure that integrates various models and technologies to improve analytical capabilities and support complex research workflows.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/HDRN:1792415794308</loc>
    <lastmod>2026-10-19T13:16:34.308Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.benzinga.com/files/images/story/2026/10/19/Crypto-Trader-Investor-Broker-Using-Smar.jpg?width=250&amp;height=187</image:loc>
      <image:title>This MannKind Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday</image:title>
      <image:caption>Chardan Capital analyst Andreas Argyrides initiated coverage on MannKind Corp (NASDAQ: MNKD) with a Buy rating and set a price target of $10, while the stock closed at $3.04 on Friday. This is part of a broader trend where various analysts have begun coverage on multiple companies, including Rush Street Interactive and Hadron Energy, with differing ratings and price targets. Hadron Energy, for example, was rated Buy with a target of $4.5, closing at $0.66.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/TEAM:1792415784601</loc>
    <lastmod>2026-10-19T13:16:24.601Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/TEAM/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Keybanc Maintains Overweight on Atlassian, Raises Price Target to $235</image:title>
      <image:caption>Keybanc analyst Jason Celino has maintained an Overweight rating on Atlassian (NASDAQ: TEAM) and raised the price target from $185 to $235. This adjustment reflects a positive outlook on the company&#39;s performance.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/AMZN:1792415772882</loc>
    <lastmod>2026-10-19T13:16:12.882Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.benzinga.com/files/images/story/2026/10/19/Jeff-Bezos--The-Founder-Of-Amazon--Speak.jpg?width=250&amp;height=187</image:loc>
      <image:title>Amazon Stock Edges Higher Monday: What&amp;#39;s Going On?</image:title>
      <image:caption>Amazon.com Inc. (NASDAQ: AMZN) shares rose 2.08% to $255.19 after Morgan Stanley named it a top pick and raised its price target from $335 to $350, indicating a potential upside of about 40%. The analyst also increased AWS revenue growth forecasts for 2027 and 2028 to 47% and 42%, respectively. Additionally, Amazon is funding a 960 MW nuclear project in Indiana in partnership with X-Energy and American Electric Power, aiming to develop nearly a gigawatt of carbon-free power. Amazon is set to report its third-quarter results on October 29, with analysts estimating earnings per share of $1.96 and revenue of $202.21 billion.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/BCDA:1792415766357</loc>
    <lastmod>2026-10-19T13:16:06.357Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/BCDA/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>BioCardia Receives FDA Acceptance For Its Pre-Submission Package For Marketing Clearance Of Its Helix Catheter For Therapeutic And Diagnostic Agent Delivery</image:title>
      <image:caption>BioCardia, Inc. (NASDAQ: BCDA) announced that the FDA has accepted its pre-submission package for marketing clearance of its Helix catheter, which is designed for therapeutic and diagnostic agent delivery. This development marks a significant step for the company in advancing its product offerings in the cardiovascular and pulmonary disease treatment market.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/MKSI:1792415628352</loc>
    <lastmod>2026-10-19T13:13:48.352Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/MKSI/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>MKS shares are trading higher after the company announced it will sell its Ophir Optics Business to TTM Technologies.</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/EXEL:1792415509547</loc>
    <lastmod>2026-10-19T13:11:49.547Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/EXEL/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Citizens Maintains Market Outperform on Exelixis, Raises Price Target to $65</image:title>
      <image:caption>Citizens analyst Silvan Turkcan has maintained a Market Outperform rating on Exelixis (NASDAQ: EXEL) and raised the price target from $55 to $65. This adjustment reflects a positive outlook on the company&#39;s performance in the market.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/NTRA:1792415386356</loc>
    <lastmod>2026-10-19T13:09:46.356Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/NTRA/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Canaccord Genuity Maintains Buy on Natera, Raises Price Target to $500</image:title>
      <image:caption>Canaccord Genuity analyst Kyle Mikson has maintained a &#39;Buy&#39; rating on Natera (NASDAQ: NTRA) and increased the price target from $375 to $500. This adjustment reflects a positive outlook for the company&#39;s performance.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/PACB:1792415357612</loc>
    <lastmod>2026-10-19T13:09:17.612Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/PACB/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>PacBio And Verily Health Announce Multi-Year Strategic Collaboration To Integrate PacBio HiFi Sequencing With Verily Health’s Governed Data And AI Platform</image:title>
      <image:caption>PacBio (NASDAQ: PACB) and Verily Health Inc. have announced a multi-year strategic collaboration to integrate PacBio&#39;s HiFi sequencing technology with Verily&#39;s governed data and AI platform. This partnership aims to combine long-read genomic data with real-world clinical data, creating AI-ready clinico-genomic datasets to enhance biomedical discovery and AI model training. The collaboration addresses challenges in processing complex biological data and aims to make genomic insights more accessible for future biomedical AI applications.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/PEBK:1792415235943</loc>
    <lastmod>2026-10-19T13:07:15.943Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/PEBK/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Peoples Bancorp of NC Q3 EPS $1.05 Up From $0.67 YoY, Sales $23.380M Up From $22.246M YoY</image:title>
      <image:caption>Peoples Bancorp of NC (NASDAQ: PEBK) reported Q3 earnings of $1.05 per share, a 56.72% increase from $0.67 per share year-over-year. The company&#39;s sales reached $23.380 million, reflecting a 5.10% rise from $22.246 million in the same quarter last year.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/CRWV:1792415227945</loc>
    <lastmod>2026-10-19T13:07:07.945Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/CRWV/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>CoreWeave shares are trading higher after Goldman Sachs upgraded the stock from Neutral to Buy and announced a $106 price target.</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/AMZN:1792415211632</loc>
    <lastmod>2026-10-19T13:06:51.632Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/AMZN/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Amazon Opens Its AWS Trainium AI Chips To Every PyTorch Developer, No Rewrite Needed</image:title>
      <image:caption>Amazon has announced that its AWS Trainium AI chips are now accessible to all PyTorch developers without the need for code rewrites. This move aims to enhance the performance and efficiency of AI model training on AWS. The availability of Trainium chips is expected to strengthen Amazon&#39;s position in the cloud computing market, particularly in AI services.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/CENT:1792415167026</loc>
    <lastmod>2026-10-19T13:06:07.026Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/CENT/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Central Garden &amp;amp; Pet Co Acquires W. Atlee Burpee, Terms Undisclosed</image:title>
      <image:caption>Central Garden &amp; Pet Company (NASDAQ:CENT) has acquired W. Atlee Burpee Company, a well-known brand in the seed and plant categories, with the transaction closing on September 30, 2026. The terms of the acquisition were not disclosed. Burpee will remain a separate entity, headquartered in Pennsylvania, with its current CEO, Jamie Mattikow, continuing to lead the business.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/SOXX:1792415087700</loc>
    <lastmod>2026-10-19T13:04:47.700Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.benzinga.com/files/images/story/2026/10/19/Creative-Ai-Background-With-Forex-Chart-.jpg?width=250&amp;height=187</image:loc>
      <image:title>Are Companies Reducing AI Spending? Chip Orders Say Otherwise</image:title>
      <image:caption>The iShares Semiconductor ETF (NASDAQ: SOXX) fell 11.8% last week, marking its longest losing streak since 2006, as fears grow that the AI boom may be losing momentum. Major chipmakers like Applied Materials Inc. and Micron Technology Inc. saw declines of 19.3% and 14.6%, respectively. Despite concerns about reduced AI spending, Bank of America analysts predict a robust future for the sector, estimating capital spending by cloud providers to reach $1.01 trillion by 2026, a 98% increase from last year. Additionally, Cantor Fitzgerald reported that chip equipment is effectively sold out, indicating strong demand in the industry.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/AIOS:1792415067513</loc>
    <lastmod>2026-10-19T13:04:27.513Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/AIOS/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>AIOS Tech To Acquire SmartCore For ~33.3M AIOS Shares Valued At ~$100M</image:title>
      <image:caption>AIOS Tech has entered into a transaction agreement to acquire SmartCore Holdings Limited for approximately $100 million, issuing 33,333,334 Class A common shares valued at $3.00 each. Following the transaction, the Sellers are expected to hold about 80.16% of AIOS&#39;s total shares and 6.21% of its voting power. The acquisition is contingent upon a series of restructuring arrangements and is expected to close by November 30, 2026. The Target Group will focus on IDC Interconnection Services and IDC Services, enhancing AIOS&#39;s offerings in the Greater Bay Area and Southeast Asia.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/CDNA:1792415060341</loc>
    <lastmod>2026-10-19T13:04:20.341Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/CDNA/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Canaccord Genuity Maintains Buy on CareDx, Raises Price Target to $80</image:title>
      <image:caption>Canaccord Genuity analyst Kyle Mikson has maintained a &#39;Buy&#39; rating on CareDx (NASDAQ: CDNA) and raised the price target from $65 to $80.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/FSI:1792415046724</loc>
    <lastmod>2026-10-19T13:04:06.724Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/FSI/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Flexible Solutions International Reports Q3 Sales Of $14.35M, Up 36% YoY</image:title>
      <image:caption>Flexible Solutions International, Inc. (NYSE-AMERICAN: FSI) reported third quarter (Q3) 2026 sales of $14.35 million, marking a 36% increase from $10.56 million in Q3 2025. The company specializes in biodegradable polymers for various applications, including oil extraction and water treatment, and is expanding into the food and nutrition supplement markets.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/AJG:1792414999031</loc>
    <lastmod>2026-10-19T13:03:19.031Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/AJG/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Arthur J. Gallagher Acquires Australian Digital Employee Communications Firm Intelligent Communications Experiences; No Financial Terms Disclosed</image:title>
      <image:caption>Arthur J. Gallagher &amp; Co. has acquired Intelligent Communications Experiences, a digital employee communications firm based in Melbourne, Australia. The financial terms of the acquisition were not disclosed. The team from Intelligent Communications Experiences will report to Graham Campbell, who oversees Gallagher&#39;s employee benefits and HR consulting operations in Australia and New Zealand.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/XBIT:1792414992518</loc>
    <lastmod>2026-10-19T13:03:12.518Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/XBIT/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>XBiotech Announces Data From Its Phase II Portion Of Multicenter TASKIN Clinical Study Meets Pre-Specifed Primary Efficacy Success Criterion Under Simon Two-Stage Design; 61.3% Participants In Vilamakitug Experimental Arm Were Alive, Surpassing Threshold Of 42, More Surviving Patients</image:title>
      <image:caption>XBiotech Inc. (NASDAQ: XBIT) reported positive results from the Phase II portion of its TASKIN clinical trial, demonstrating that 61.3% of participants in the vilamakitug experimental arm were alive at the 12-month mark, exceeding the required threshold of 42. The study, which evaluated the effectiveness of XBiotech&#39;s anti-IL-1α monoclonal antibody XB2001 combined with standard chemotherapy for patients with refractory metastatic colorectal cancer, showed that 49 out of 80 evaluable patients in the experimental group survived, compared to 55.7% survival in the control group.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/KTCC:1792414902544</loc>
    <lastmod>2026-10-19T13:01:42.544Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/KTCC/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Key Tronic Signs LoI With TP-Link Systems To Bring Next-Generation Assembly To The U.S.</image:title>
      <image:caption>Key Tronic has signed a Letter of Intent (LOI) with TP-Link Systems to become a primary domestic manufacturing partner, focusing on the assembly of TP-Link&#39;s advanced networking products in Corinth, Mississippi. Subject to U.S. regulatory approval, the domestic assembly of TP-Link&#39;s Wi-Fi 8 product line is anticipated to start as early as next year. This partnership aligns with Key Tronic&#39;s strategy to enhance its domestic manufacturing capabilities.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/RTX:1792414867108</loc>
    <lastmod>2026-10-19T13:01:07.108Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/RTX/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Raytheon, Lockheed Martin Joint Venture Receives $215M U.S. Army Production Contract For Lightweight Commercial Launch Units</image:title>
      <image:caption>The Javelin Joint Venture (JJV), a collaboration between Raytheon and Lockheed Martin, has been awarded a $215 million contract by the U.S. Army for the production of Lightweight Command Launch Units (LWCLU) for the Javelin weapon system. This next-generation launcher is designed to be compatible with all Javelin variants. The contract follows the delivery of the first LWCLUs to the Army five months prior.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/PCTY:1792414747219</loc>
    <lastmod>2026-10-19T12:59:07.219Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.benzinga.com/files/images/story/2026/10/19/United-States-Tariffs-Government-Import-.jpg?width=250&amp;height=187</image:loc>
      <image:title>Top 3 Industrials Stocks That May Collapse This Quarter</image:title>
      <image:caption>As of October 19, 2026, three industrial stocks are identified as potentially overbought: Relx PLC (NYSE: RELX) with an RSI of 72.4 and a recent stock price of $39.06, Paylocity Holding Corp (NASDAQ: PCTY) with an RSI of 70.4 and a stock price of $166.32, and RXO Inc (NYSE: RXO) with an RSI of 73 and a stock price of $28.60. RXO is set to be acquired by C.H. Robinson, which has contributed to a 42% stock gain over the past month. Relx and Paylocity both experienced stock gains of approximately 14% over the same period.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/REZI:1792414646933</loc>
    <lastmod>2026-10-19T12:57:26.933Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/REZI/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Citizens Initiates Coverage On Resideo Technologies with Market Outperform Rating, Announces Price Target of $22</image:title>
      <image:caption>Citizens analyst Aaron Kimson has initiated coverage on Resideo Technologies (NYSE: REZI) with a Market Outperform rating. The analyst has set a price target of $22 for the company&#39;s stock.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/SAFX:1792414597833</loc>
    <lastmod>2026-10-19T12:56:37.833Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/SAFX/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Why XCF Global Stock Is Surging Monday</image:title>
      <image:caption>XCF Global Inc. (NASDAQ: SAFX) experienced a 32.50% increase in stock price during premarket trading, reaching $0.18, following the completion of its merger with Southern Energy Renewables and DevvStream. The company raised its 2027 financial outlook, targeting gross product sales of $650 million to $700 million and net revenue of $120 million to $130 million. Additionally, XCF reported over $12 million in gross product sales for September and a daily production rate of approximately 85,000 gallons at its Reno facility.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/SAFX:1792414549254</loc>
    <lastmod>2026-10-19T12:55:49.254Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.benzinga.com/files/images/story/2026/10/19/Investors-Show-Virtual-Screen-Stock-Mark.jpg?width=250&amp;height=187</image:loc>
      <image:title>Why XCF Global Stock Is Surging Monday</image:title>
      <image:caption>XCF Global Inc. (NASDAQ: SAFX) saw its stock surge by 32.50% to $0.18 in premarket trading following the completion of its all-stock merger with Southern Energy Renewables and DevvStream. The merger allows XCF to enhance its renewable fuel capabilities, with a 2027 financial outlook projecting gross product sales of $650 million to $700 million and net revenue of $120 million to $130 million. Additionally, the company reported over $12 million in gross product sales in September and aims to increase production at its Reno facility, which has a capacity of 38 million to 40 million gallons annually.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/OBAI:1792414500666</loc>
    <lastmod>2026-10-19T12:55:00.666Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/OBAI/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Trading Halt: Halt status updated at 8:55:00 AM ET: Quotation Resumption: News and Resumption Times</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/NOW:1792414495495</loc>
    <lastmod>2026-10-19T12:54:55.495Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/NOW/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>StoneX Maintains Buy on ServiceNow, Raises Price Target to $165</image:title>
      <image:caption>StoneX analyst Yi Fu Lee has maintained a &#39;Buy&#39; rating on ServiceNow (NYSE: NOW) and increased the price target from $130 to $165. This adjustment reflects a positive outlook on the company&#39;s performance.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/MSTR:1792414456886</loc>
    <lastmod>2026-10-19T12:54:16.886Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.benzinga.com/files/images/story/2026/10/19/Strategy-Inc.jpg?width=250&amp;height=187</image:loc>
      <image:title>Michael Saylor &amp;#39;Found More Room for Orange&amp;#39; as Strategy Adds 267 Bitcoin</image:title>
      <image:caption>Strategy (NASDAQ: MSTR) purchased 267 Bitcoin for $22.1 million between October 12 and October 18, bringing its total Bitcoin holdings to 848,517 BTC, acquired for approximately $64.02 billion at an average price of $75,446 per coin. The company funded this acquisition primarily by selling 140,872 shares of MSTR stock. Following recent MSCI index rule changes, MSTR&#39;s stock fell 9.5% but rebounded 2% in premarket trading, currently standing above its 50-day EMA at $139.50.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/DDOG:1792414348195</loc>
    <lastmod>2026-10-19T12:52:28.195Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/DDOG/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Datadog shares are trading higher after Bernstein upgraded the stock from Market Perform to Outperform and raised its price target from $237 to $350.</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/PYPL:1792414152688</loc>
    <lastmod>2026-10-19T12:49:12.688Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.benzinga.com/files/images/story/2026/10/19/Paypal-Signage--San-Jose--Ca--May-6--201.jpg?width=250&amp;height=187</image:loc>
      <image:title>Why Is PayPal Stock Trending Monday?</image:title>
      <image:caption>PayPal Holdings Inc. (NASDAQ: PYPL) is trending due to renewed speculation of a potential all-stock takeover by an unnamed West Coast tech company, following an unconfirmed report from September. The stock is currently under selling pressure, trading 1.94% lower at $55.60. PayPal is set to report its third-quarter earnings on October 27, with analysts estimating earnings per share of $1.31 and revenue of $8.71 billion, while the company has raised its full-year non-GAAP earnings per share outlook to about $5.38.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/ONMD:1792414050148</loc>
    <lastmod>2026-10-19T12:47:30.148Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/ONMD/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>OneMedNet Enters Its 12th Channel Partner Agreement With A Global Pharmaceutical Intelligence And Data Solutions Provider To Distribute Its Clinical Data; Terms Not Disclosed</image:title>
      <image:caption>OneMedNet has entered its 12th channel partner agreement with a global pharmaceutical intelligence and data solutions provider to distribute its clinical data, although the terms of the agreement were not disclosed. This partnership aims to enhance OneMedNet&#39;s presence in the rapidly growing Real-World Data market, projected to increase from approximately $2.7 billion in 2026 to $7.1 billion by 2033. The company emphasizes the value of its first-party data sourced directly from healthcare providers, which is de-identified and delivered at regulatory-grade quality, supporting pharmaceutical customers in various areas including clinical development and regulatory submissions.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/EXYN:1792413916432</loc>
    <lastmod>2026-10-19T12:45:16.432Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/EXYN/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>EXCLUSIVE: Exyn Joins Department Of Energy Backed Mining Project to Hunt for Critical Minerals</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/EXYN:1792413909511</loc>
    <lastmod>2026-10-19T12:45:09.511Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.benzinga.com/files/images/story/2026/10/19/Stuttgart--Germany---08-07-2026-In-This-.jpg?width=250&amp;height=187</image:loc>
      <image:title>EXCLUSIVE: Exyn Joins DOE-Backed Mining Project to Hunt for Critical Minerals</image:title>
      <image:caption>Exyn Technologies Inc. has joined the DOE-backed Mining Autonomous Platform for Prospecting and Ore Discovery (MAP-POD) project, contributing its ExynAI near-zero drift navigation technology aimed at enhancing underground mapping and mineral discovery. The U.S. Department of Energy selected MAP-POD for funding as part of its Mine of the Future Initiative, which includes a total of $29.5 million for 17 projects. This initiative seeks to bolster U.S. mining capabilities and reduce reliance on foreign supply chains. Exyn&#39;s stock was down 2.04% at $1.92 during premarket trading.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/SPRC:1792413547661</loc>
    <lastmod>2026-10-19T12:39:07.661Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/SPRC/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>SciSparc Shifts Strategic Focus To Agentic AI, Targeting Cybersecurity And Financial Finance Technologies</image:title>
      <image:caption>SciSparc Ltd. (NASDAQ: SPRC) is shifting its strategic focus towards Agentic AI technologies, specifically in cybersecurity and finance. This decision follows previous announcements regarding the establishment of a Scientific Advisory Board for AI and Cybersecurity. The company plans to explore technologies and business opportunities within the Agentic AI ecosystem, although there is no guarantee that these efforts will lead to revenue-generating activities.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/NVAX:1792413535681</loc>
    <lastmod>2026-10-19T12:38:55.681Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.benzinga.com/files/images/story/2026/10/19/Novavax-Vaccine.jpg?width=250&amp;height=187</image:loc>
      <image:title>Novavax&amp;#39;s Second-Largest Shareholder Sells $32.6 Million in Stock, Ends Activist Push</image:title>
      <image:caption>Novavax Inc. (NASDAQ: NVAX) major shareholder Shah Capital sold 2.87 million shares for approximately $32.6 million, ending its activist investment strategy as part of a family office restructuring. The shares were sold at an average price of $11.35 each, and Shah Capital has withdrawn its SEC registration as an investment adviser. Despite the sale, Himanshu Shah retains 10.66 million shares, representing 6.46% of Novavax. The company’s stock was trading at $11.30, up 0.36% in premarket activity.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://openbell.ai/news/NRXP:1792413500625</loc>
    <lastmod>2026-10-19T12:38:20.625Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/NRXP/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>NRx Pharmaceuticals Completes Three Process Validation Lots Of Preservative Free Ketamine Produced Under Commercial Conditions In Anticipation Of Nov. 10 Generic Drug User Fee Amendments Goal Date</image:title>
      <image:caption>NRx Pharmaceuticals has completed three Process Validation lots of preservative-free Ketamine under commercial conditions, in preparation for the November 10 GDUFA goal date. The company has also analyzed two-year stability data showing no deterioration in purity, potency, or sterility, suggesting a potential shelf life of three years or longer. This completion is a key step in demonstrating compliance with FDA Good Manufacturing Practices.</image:caption>
    </image:image>
  </url>
</urlset>